Ocular therapies for neuronal ceroid lipofuscinoses: more than meets the eye.
作者信息
Murray Samantha J, Mitchell Nadia L
机构信息
Faculty of Agricultural and Life Sciences, Lincoln University, Lincoln, New Zealand.
出版信息
Neural Regen Res. 2022 Aug;17(8):1755-1756. doi: 10.4103/1673-5374.332148.
Abstract
摘要
相似文献
1
Ocular therapies for neuronal ceroid lipofuscinoses: more than meets the eye.用于神经元蜡样脂褐质沉积症的眼部疗法：不止于表面所见。
Neural Regen Res. 2022 Aug;17(8):1755-1756. doi: 10.4103/1673-5374.332148.
2
Ocular Manifestations of Neuronal Ceroid Lipofuscinoses.神经元蜡样脂褐质沉积症的眼部表现。
Semin Ophthalmol. 2021 Oct 3;36(7):582-595. doi: 10.1080/08820538.2021.1936571. Epub 2021 Jun 9.
3
Expanding the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses.扩展神经元蜡样脂褐质沉积症的神经影像学表型。
AJNR Am J Neuroradiol. 2020 Oct;41(10):1930-1936. doi: 10.3174/ajnr.A6726. Epub 2020 Aug 27.
4
Occurrence of and mortality from childhood neuronal ceroid lipofuscinoses in norway.挪威儿童神经元蜡样脂褐质沉积症的发病率及死亡率
J Child Neurol. 2006 Nov;21(11):917-22. doi: 10.1177/08830738060210110801.
5
Clinical, electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes.68 例神经元蜡样脂褐质沉积症及其亚型的临床、电生理、影像学和超微结构描述。
Pediatr Neurol. 2014 Jan;50(1):85-95. doi: 10.1016/j.pediatrneurol.2013.08.008. Epub 2013 Oct 10.
6
Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses.神经元蜡样脂褐质沉积症的现行和新兴治疗策略。
CNS Drugs. 2019 Apr;33(4):315-325. doi: 10.1007/s40263-019-00620-8.
7
Seizure susceptibility, phenotype, and resultant growth delay in the nclf and mnd mouse models of neuronal ceroid lipofuscinoses.神经元蜡样脂褐质沉积症的nclf和mnd小鼠模型中的癫痫易感性、表型及由此导致的生长迟缓。
J Child Neurol. 2013 Sep;28(9):1137-41. doi: 10.1177/0883073813493667. Epub 2013 Jul 9.
8
Hippocampal lesions in the neuronal ceroid lipofuscinoses.神经元蜡样脂褐质沉积症中的海马病变
Eur J Paediatr Neurol. 2001;5 Suppl A:209-11. doi: 10.1053/eipn.2000.0464.
9
Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network.来自巴滕动物研究网络（BARN）的绵羊神经元蜡样脂褐质沉积症的最新研究。
Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2279-86. doi: 10.1016/j.bbadis.2015.06.013. Epub 2015 Jun 12.
10
Gene Therapy Approaches to Treat the Neurodegeneration and Visual Failure in Neuronal Ceroid Lipofuscinoses.基因治疗方法治疗神经鞘脂沉积症的神经退行性变和视力丧失。
Adv Exp Med Biol. 2018;1074:91-99. doi: 10.1007/978-3-319-75402-4_12.
引用本文的文献
1
Genetic Reasons for Phenotypic Diversity in Neuronal Ceroid Lipofuscinoses and High-Resolution Imaging as a Marker of Retinal Disease.神经元蜡样脂褐质沉积症表型多样性的遗传原因及高分辨率成像作为视网膜疾病的标志物
Ophthalmol Sci. 2024 May 29;4(6):100560. doi: 10.1016/j.xops.2024.100560. eCollection 2024 Nov-Dec.
2
Experimental Therapeutic Approaches for the Treatment of Retinal Pathology in Neuronal Ceroid Lipofuscinoses.治疗神经元蜡样脂褐质沉积症视网膜病变的实验性治疗方法
Front Neurol. 2022 Apr 18;13:866983. doi: 10.3389/fneur.2022.866983. eCollection 2022.
本文引用的文献
1
Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease.玻璃体内基因治疗可预防 CLN5 神经鞘脂贮积症羊的视网膜功能障碍和变性。
Exp Eye Res. 2021 Jun;207:108600. doi: 10.1016/j.exer.2021.108600. Epub 2021 Apr 28.
2
Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice.向颅内递送AAV9基因疗法可部分预防CLN6型贝敦氏病小鼠的视网膜变性和视觉缺陷。
Mol Ther Methods Clin Dev. 2021 Jan 5;20:497-507. doi: 10.1016/j.omtm.2020.12.014. eCollection 2021 Mar 12.
3
Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis.玻璃体内酶替代治疗可保存犬 CLN2 神经元蜡样脂褐质沉积症的视网膜结构和功能。
Exp Eye Res. 2020 Aug;197:108130. doi: 10.1016/j.exer.2020.108130. Epub 2020 Jul 1.
4
Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.基因治疗靶向内视网膜可挽救 CLN3 神经鞘脂贮积病小鼠模型的视网膜表型。
Hum Gene Ther. 2020 Jul;31(13-14):709-718. doi: 10.1089/hum.2020.038.
5
A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.经枕大池蛛网膜下腔腔隙安全可靠地递送达神经中枢的 AAV 载体技术。
Mol Ther. 2020 Feb 5;28(2):411-421. doi: 10.1016/j.ymthe.2019.11.012. Epub 2019 Nov 16.
6
Longitudinal In Vivo Monitoring of the CNS Demonstrates the Efficacy of Gene Therapy in a Sheep Model of CLN5 Batten Disease.体内纵向监测中枢神经系统证明了基因治疗在 CLN5 神经鞘脂贮积病绵羊模型中的疗效。
Mol Ther. 2018 Oct 3;26(10):2366-2378. doi: 10.1016/j.ymthe.2018.07.015. Epub 2018 Jul 17.
7
Prevention of Photoreceptor Cell Loss in a Cln6 Mouse Model of Batten Disease Requires CLN6 Gene Transfer to Bipolar Cells.预防感光细胞丧失在 CLN6 基因突变致神经鞘脂贮积病的鼠模型中需要 CLN6 基因转染双极细胞。
Mol Ther. 2018 May 2;26(5):1343-1353. doi: 10.1016/j.ymthe.2018.02.027. Epub 2018 Mar 2.
8
Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis.玻璃体内植入转导TPP1的干细胞可延缓犬类CLN2神经元蜡样脂褐质沉积症的视网膜变性。
Exp Eye Res. 2016 Nov;152:77-87. doi: 10.1016/j.exer.2016.09.003. Epub 2016 Sep 13.
9
AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease.腺相关病毒基因转移可延缓晚期婴儿型神经元蜡样脂褐质沉积症（Batten病）TPP1缺陷犬模型的疾病发作。
Sci Transl Med. 2015 Nov 11;7(313):313ra180. doi: 10.1126/scitranslmed.aac6191.
10
Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis.酶替代疗法可延迟婴儿晚期神经元蜡样脂褐质沉积症犬模型的瞳孔光反射缺陷。
Exp Eye Res. 2014 Aug;125:164-72. doi: 10.1016/j.exer.2014.06.008. Epub 2014 Jun 19.
Zotero 插件